Literature DB >> 17234129

Genetic tools to tailor cancer prevention by NSAIDs.

Cornelia M Ulrich1, Jeannette Bigler, John D Potter.   

Abstract

It was shown that NSAIDs, such as aspirin or Celebrex, are effective cancer preventive agents when taken regularly. However, the long-term use of NSAIDs, the cyclooxygenase (COX) inhibitors, may have significant adverse effects - primarily on the gastrointestinal (inhibiting COX-1) and cardiovascular (inhibiting COX-2) systems. Genetic analysis of enzymes (including COX) involved in the prostaglandin synthesis should reveal and predict a person's benefits vs. toxicity resulting from the NSAID treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17234129

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  2 in total

1.  Evaluation of white blood cell count as a possible prognostic marker for oral cancer.

Authors:  Astrid L Kruse; Heinz T Luebbers; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2011-02-27

Review 2.  The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.

Authors:  Tara Karnezis; Ramin Shayan; Stephen Fox; Marc G Achen; Steven A Stacker
Journal:  Oncotarget       Date:  2012-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.